Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 1Phase 1 1

Status

Completed 29Terminated 5Recruiting 5Active not recruiting 5Unknown 4Withdrawn 3

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 92Thoracic 46CNS 35Breast 31Gynecologic 20Genitourinary 18Sarcoma 13Lymphoid 7Dermatologic 5Tumor-Agnostic 4Other solid neoplasm 4Other hematologic neoplasm 4Myeloid 3Head & Neck 3Plasma cell 2Endocrine 2NET 1Classical hematology 1

Conditions

Melanoma 4Uveal Melanoma 1Non-Muscle Invasive Bladder Neoplasms 1Neoplasm Metastasis 1Macular Edema 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Brain Neoplasms 1

Interventions

pembrolizumab 58Cyclophosphamide 53Ipilimumab 52Nivolumab 44aldesleukin 35Interleukin-2 26fludarabine phosphate 22fludarabine 21Vemurafenib 20Temozolomide 19Radiotherapy 18dabrafenib 15trametinib 12Radiosurgery 11CTLA-4 Antigen 11Filgrastim 10Dacarbazine 10spartalizumab 9cobimetinib 9binimetinib 9atezolizumab 9Biopsy 9poly ICLC 8Paclitaxel 8Antilymphocyte Serum 8encorafenib 7avelumab 7Rituximab 7Introns 7romidepsin 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Terminated × Bevacizumab × Dermatologic × Clear all
NCT03698162 2025-08-05

Precise DCE-MRI in Diagnosing Participants With Recurrent High Grade Glioma or Melanoma Brain Metastases

University of Southern California

Phase NA Terminated
15 enrolled
CNSDermatologic

Brain Neoplasms, Melanoma

NCT06448364 2024-11-06

LTbR

Pfizer

Phase 1 Terminated
4 enrolled
DermatologicGastrointestinalGenitourinaryThoracic

Non-Muscle Invasive Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Melanoma, Neoplasm Metastasis, Colorectal Neoplasms

NCT01471054 2019-09-03

Dexamethasone Intravitreal Implant for Treatment of Macular Edema After Plaque Radiotherapy of Uveal Melanoma

Wills Eye

Phase 2 Terminated
6 enrolled 10 charts
Dermatologic

Uveal Melanoma, Macular Edema

NCT01495988 2017-10-24

Trial of Vemurafenib/Cobimetinib With or Without Bevacizumab in Patients With Stage IV BRAFV600 Mutant Melanoma

Melanoma Research Foundation Breakthrough Consortium

Phase 2 Terminated
10 enrolled 10 charts
Dermatologic

Melanoma

NCT01705392 2017-02-24

Bevacizumab vs Dacarbazine in Metastatic Melanoma

Haukeland University Hospital

Phase 2 Terminated
2 enrolled
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡